Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease.

@article{Yilmaz2011LowTA,
  title={Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease.},
  author={Mahmut Ilker Yilmaz and A. Sait Sonmez and Murat Karaman and Seyit Ahmet Ay and Mutlu Sağlam and H. Ruhi Yaman and Selim Kiliç and Tayfun Eyileten and Kayser Cağlar and Yusuf Oğuz and A. Gural Vural and Mujdat Yenicesu and Carmine Zoccali},
  journal={American journal of nephrology},
  year={2011},
  volume={33 1},
  pages={25-32}
}
BACKGROUND/AIMS Subclinical or frank hypothyroidism is causally implicated in endothelial dysfunction. Since the plasma concentration of the active form of thyroid hormone, triiodothyronine (T₃), is reduced in chronic kidney disease (CKD), where endothelial function is frequently altered, low T₃ may be a factor implicated in this disturbance in CKD patients. METHODS We investigated the relationship between flow-mediated vasodilatation (FMD) and thyroid hormones in a series of 217 nondiabetic… CONTINUE READING